CHINA GEWANG BIOTECHNOLOGY, INC. - Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Nov. 30, 2015	Nov. 30, 2014
Cash flows from operating activities:
Net income	$ 1,188,713	$ 793,656
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	32,121	25,962
Changes in operating assets and liabilities:
(Increase) in accounts receivable	(267,868)
(Increase) in inventory	(102,782)	(53,996)
(Increase) in prepaid expenses	(96,169)	(90,470)
(Decrease) in accounts payable	(7,225)
(Decrease) increase in advances from customers	(56,930)	14,997
Increase in taxes payable	16,824	29,345
Increase in accrued expenses and other liabilities	330,936	9,410
Net cash provided by operating activities	1,037,620	728,904
Cash flows from investing activities:
Purchase of equipment	(52,485)	(6,676)
Net cash (used in) investing activities	(52,485)	(6,676)
Cash flows from financing activities:
Proceeds from sale of common stock	5,000,000
Net cash provided by financing activities	5,000,000
Effect of exchange rate changes on cash	(328,913)	1,366
Net change in cash	5,656,222	723,594
Cash, Beginning of Period	3,012,812	2,289,218
Cash, End of Period	$ 8,669,034	$ 3,012,812
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
Cash paid income taxes	$ 446,012	$ 238,026
Noncash financing activities;
Payment of accrued expenses and other payables by shareholder	$ 159,689	$ 6,417